Angiotensin Type-1 Receptor A1166C Gene Polymorphism Correlates With Oxidative Stress Levels in Human Heart Failure
- 1 June 2006
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 47 (6) , 1155-1161
- https://doi.org/10.1161/01.hyp.0000222893.85662.cd
Abstract
Oxidative stress plays a critical role in the pathogenesis of cardiovascular disease and diabetes. Studies in vascular cells and experimental animals have demonstrated that the angiotensin type-1 receptor (AT1R) contributes to formation of reactive oxygen species by activating nicotinamide-adenine dinucleotide phosphate oxidases, but the relevance of this pathway to human heart disease has not been established. Here we demonstrate that a polymorphism in the AT1R gene (A1166C), linked to increased receptor activity, is associated with elevated levels of oxidative stress markers in heart failure patients but not in healthy controls. Plasma protein carbonyls (PCs), a marker of oxidative protein modification, were 10-fold higher in heart-failure patients compared with controls [geometric means and 95% CIs for patients, 75 (57 to 100) pmol/mg; controls, 5 (4 to 7) pmol/mg; P P P P AT1R genotype was demonstrated to be an independent predictor of both PCs and myeloperoxidase levels in heart-failure patients. These findings suggest that oxidative stress in human heart failure is regulated via angiotensin signaling and may involve the nicotinamide dinucleotide oxidase pathway.Keywords
This publication has 35 references indexed in Scilit:
- Large Eustachian valve and kyphoscoliosisHeart, 2005
- This Week in the JournalNew England Journal of Medicine, 2003
- Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary SyndromesCirculation, 2003
- Increased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stressHeart, 2003
- Myeloperoxidase and Plasminogen Activator Inhibitor 1 Play a Central Role in Ventricular Remodeling after Myocardial InfarctionThe Journal of Experimental Medicine, 2003
- NAD(P)H Oxidase-Derived Reactive Oxygen Species as Mediators of Angiotensin II SignalingAntioxidants and Redox Signaling, 2002
- Angiotensin II Stimulation of NAD(P)H Oxidase ActivityCirculation Research, 2002
- Macrophage Myeloperoxidase Regulation by Granulocyte Macrophage Colony-Stimulating Factor in Human Atherosclerosis and Implications in Acute Coronary SyndromesThe American Journal of Pathology, 2001
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- A Simple Molecular Assay for the C1166 Variant of the Angiotensin II Type 1 Receptor GeneBiochemical and Biophysical Research Communications, 1995